News

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

Novo's new CEO faces sceptical investors with Wegovy US sales in focus

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...
Devdiscourse21h

Novo Nordisk CEO Faces Investor Challenge Amidst Marketplace Turmoil

Novo Nordisk's new CEO, Maziar Mike Doustdar, is tasked with revitalizing the company's flagging sales and addressing ...

Instant View: Reaction to new Novo Nordisk CEO, profit warning

Novo's problems are much deeper than just compunded Wegovy in the U.S. and extend to the international Wegovy franchise and ...

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
Devdiscourse1d

Pharma Industry Shaken: New Leadership and Tariff Challenges

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...